scholarly journals Sickle cell trait and priapism: a case report and review of the literature

Cases Journal ◽  
2008 ◽  
Vol 1 (1) ◽  
Author(s):  
Brian F Birnbaum ◽  
Joseph J Pinzone
2017 ◽  
Vol 10 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Madhumati R. Kalavar ◽  
Sami Ali ◽  
Damoun Safarpour ◽  
Saroj Davi Kunnakkat

Renal medullary carcinoma (RMC) is a rare, yet aggressive malignancy of the kidney that is found predominantly in young patients with African descent and sickle cell hemoglobinopathies and most specifically sickle cell trait. Due to its aggressive nature, most cases have metastasis or local invasion at the time of diagnosis. Prognosis is extremely poor with survival less than 1 year after diagnosis. Here we present a case of metastatic RMC in a 29-year-old African female. Despite chemotherapy with cisplatin, gemcitabine, and paclitaxel, and initial shrinkage of the tumor, the patient died 5 months after diagnosis.


2020 ◽  
Vol 27 (1) ◽  
Author(s):  
P. Holland ◽  
J. Merrimen ◽  
C. Pringle ◽  
L. A. Wood

Renal medullary carcinoma (rmc) is a rare and aggressive renal malignancy that usually presents at an advanced stage, has a poor prognosis, and is associated with sickle cell trait. We present a case of rmc including radiologic and pathology findings, treatment, and outcome. A review of the literature is also presented, with an emphasis on the association of rmc with sickle cell trait, which was an unknown diagnosis in our patient preoperatively.


2021 ◽  
pp. 100047
Author(s):  
Álvaro Alejandre-de-Oña ◽  
Jaime Alonso-Muñoz ◽  
Pablo Demelo-Rodríguez ◽  
Jorge del-Toro-Cervera ◽  
Francisco Galeano-Valle

Author(s):  
Philippe Genet ◽  
Marc Pulik ◽  
Francois Lionnet ◽  
Charlotte Petitdidier ◽  
Tahar Touahri

2017 ◽  
Vol 08 (03) ◽  
Author(s):  
Derrick Tembi Efie ◽  
Nkeangu Fomengia Joseph ◽  
Eugene Vernyuy Yeika ◽  
Simeon Pierre

Blood ◽  
1951 ◽  
Vol 6 (4) ◽  
pp. 365-371 ◽  
Author(s):  
DONALD SHOTTON ◽  
CHARLES L. CROCKETT ◽  
BYRD S. LEAVELL

Abstract 1. A case of sickle cell anemia who had numerous hemolytic crises and also hypersplenic effects such as pancytopenia was treated by splenectomy with marked improvement in general condition and in the blood. The literature relating to this subject is reviewed. Those cases with the largest spleens appear to have shown the most striking degrees of improvement. 2. In cases of sickle cell anemia showing various indications of hypersplenism, and excessive hemolysis, splenectomy may be a rational therapeutic procedure.


Sign in / Sign up

Export Citation Format

Share Document